BioWorld

June 28, 2002

View Archived Issues

FDA Grants Corixa's Appeal; Bexxar Will Go Before ODAC

Corixa Corp. won an appeal against an FDA decision issued earlier this year that required additional clinical trials in order to market the cancer drug Bexxar. (BioWorld Today) Read More

Exact Sciences, LabCorp Enter Molecular Diagnostics Alliance

Read More

'Smart Bomb' Nanoparticle, Killer Gene, Canny Receptor Team Up To Starve Tumor Of Blood Supply

Read More

BioDelivery Raises $10.5M In IPO To Fund Delivery Technology

Read More

Other News To Note

Read More